Managing neonatal hyperbilirubinemia: An updated guideline.
JAAPA
; 37(10): 19-25, 2024 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-39259272
ABSTRACT
ABSTRACT More than 80% of newborn infants experience jaundice as a result of elevated bilirubin during the first few weeks after birth. In most cases, hyperbilirubinemia is physiologic, but persistent and extreme elevations can lead to serious long-term complications, such as kernicterus. To avoid these complications and help clinicians in the successful assessment, evaluation, and treatment of hyperbilirubinemia, the American Academy of Pediatrics updated its clinical practice guideline for neonatal hyperbilirubinemia. This article reviews the guideline and highlights significant updates, such as an elevation in the threshold for phototherapy and exchange transfusion, inclusion of gestational age, and removal of racially based norms.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phototherapy
/
Practice Guidelines as Topic
/
Hyperbilirubinemia, Neonatal
Limits:
Humans
/
Newborn
Language:
En
Journal:
JAAPA
Journal subject:
MEDICINA
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos